Celano Michael
- SEC CIK
- 0001377582
No open-market purchases or sales filed in the past year.
Current role at each company
- LRMR Larimar Therapeutics, Inc.Chief Financial Officeras of Jan 27, 2026
- OSUR Orasure Technologies IncDirectoras of Aug 16, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Celano Michael as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
LRMR Larimar Therapeutics, Inc.
Chief Financial Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 18, 2023 (view filing) | May 17 | 1 day | Celano MichaelChief Financial Officer | PPurchase | +5.00K | $3.73 | +$18.6K | +4.6%112.7K after | |
| Sep 19, 2022 (view filing) | Sep 16 | 3 days | Celano MichaelChief Financial Officer | PPurchase | +31.7K | $3.15 | +$100.0K | New position31.7K after |
OSUR Orasure Technologies Inc
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2022 (view filing) | Aug 12 | 4 days | Celano MichaelDirector | PPurchase | +12.0K | $4.49 | +$53.9K | +12.0%111.8K after |